NCT03490630 Patient Reported Outcome After Bariatric Surgery
| NCT ID | NCT03490630 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Insel Gruppe AG, University Hospital Bern |
| Condition | Anesthesia |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2011-01-02 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2011-01-02 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective association study to analyse patients' outcome after bariatric surgery. Outcome comprises postoperative pain, analgesia, postoperative side-effects, long-lasting pain, patients' impairment in daily living.
Eligibility Criteria
Inclusion Criteria: * 18 years and older * Written informed consent * Elective bariatric surgery * Patients' ability to understand the purpose of the study Exclusion Criteria * No informed consent * Cognitive impairment
Contact & Investigator
Ulrike M Stamer, Prof. MD
PRINCIPAL INVESTIGATOR
Department of Anaestheisology and Pain Medicine, Inselspital, University of Bern
Frequently Asked Questions
Who can join the NCT03490630 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03490630 currently recruiting?
Yes, NCT03490630 is actively recruiting participants. Contact the research team at ulrike.stamer@dbmr.unibe.ch for enrollment information.
Where is the NCT03490630 trial being conducted?
This trial is being conducted at Bern, Switzerland.
Who is sponsoring the NCT03490630 clinical trial?
NCT03490630 is sponsored by Insel Gruppe AG, University Hospital Bern. The principal investigator is Ulrike M Stamer, Prof. MD at Department of Anaestheisology and Pain Medicine, Inselspital, University of Bern. The trial plans to enroll 2,000 participants.